IL6 and psoriasis: The lack of a robust CRP signal in psoriasis and PsA is owed to the fact that interleukin (IL)-6, the essential stimulator of CRP, plays no critical role in these diseases, which is illustrated by the very limited therapeutic effect of IL-6 neutralization in psoriatic disease [3].